. Author manuscript; available in PMC: 2014 Sep 9.

Published in final edited form as: Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528. doi: 10.1002/14651858.CD006528.pub2

Analysis 2.32. Comparison 2 Mirtazapine versus SSRIs, Outcome 32 Secondary outcome (SKEWED DATA: depression severity) at end of the acute-phase treatment.

Secondary outcome (SKEWED DATA: depression severity) at end of the acute-phase treatment

Study	Comparator drug	Measurement	Mirtazapine: mean	SD	N	Comparator: mean	SD	N
Schoemaker 2002	Fluvoxamine	HAMD-17	−14.3	7.33	199	−13.7	7.68	203
Thase 2000	Sertraline	HAMD-17	8.7	7.6	119	10.5	7.2	124
Winokur 2003	Fluoxetine	HAMD-21	7.1	3.7	8	12.2	9.2	11